Answer
Atrovent UDVs (ipratropium bromide), like other anticholinergics, should be used with caution in people with cystic fibrosis because they may be prone to gastrointestinal motility disturbances.
Sources for this answer
- Atrovent 250 UDVs, 1 ml / Atrovent UDVs, 2 mlBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 19Document updated
Sources checked